Publications by authors named "Michael van Guilder"

Claim this Profile
T
To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Sylvain Goutelle, Céline Alloux, Laurent Bourguignon, Michael Van Guilder, Michael Neely

Ther Drug Monit· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.
Michael N Neely, Lauren Kato, Gilmer Youn, Lironn Kraler, David Bayard, Michael van Guilder

Antimicrob Agents Chemother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software.
Michael Neely, Michael Philippe, Teresa Rushing, Xiaowei Fu, Michael van Guilder

Ther Drug Monit· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving target voriconazole concentrations more accurately in children and adolescents.
Michael Neely, Ashley Margol, Xiaowei Fu, Michael van Guilder, David Bayard

Antimicrob Agents Chemother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis.
George L Drusano, Michael Neely, Michael Van Guilder, Alan Schumitzky, David Brown

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.
Arnold Louie, Weiguo Liu, Michael VanGuilder, Michael N Neely, Alan Schumitzky

J Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage.
Roger W Jelliffe, Mark Milman, Alan Schumitzky, David Bayard, Michael Van Guilder

Ther Drug Monit· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian.
Tatiana Tatarinova, Michael Neely, Jay Bartroff, Michael van Guilder, Walter Yamada

J Pharmacokinet Pharmacodyn· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.
Michael N Neely, Michael G van Guilder, Walter M Yamada, Alan Schumitzky, Roger W Jelliffe

Ther Drug Monit· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonparametric population modeling and Bayesian analysis.
Roger Jelliffe, Michael Neely, Alan Schumitzky, David Bayard, Michael Van Guilder

Pharmacol Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs.
Sylvain Goutelle, Laurent Bourguignon, Pascal H Maire, Michael Van Guilder, John E Conte

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.
Andrea Kwa, Juraj Sprung, Michael Van Guilder, Roger W Jelliffe

Ther Drug Monit· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Ruediger E Port, Daniela Kiepe, Michael Van Guilder, Roger W Jelliffe, Otto Mehls

Clin Pharmacokinet· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis